Voyageur Pharmaceuticals Ltd., Announces The Completion of a New Scientific Advisory Board With World Class Leading Physicians Oct 18, 2021 Read More
Levitee Labs Announces Agreement with Adracare, a WELL Health Company, to Support Individuals with Addiction and Mental Health Conditions Oct 18, 2021 Read More
Levitee Labs Appoints Dr. Mohammed Mosli as Chief People Officer of Levitee Clinics and Pharmacies in Alberta, Canada Oct 14, 2021 Read More
Resverlogix Receives Ethics Approval for Canadian Sites in Apabetalone COVID-19 Clinical Trial Oct 12, 2021 Read More
Levitee Labs Signs Letter of Intent to Acquire Calgary Addiction and Compounding Pharmacy Oct 12, 2021 Read More
Microdose Psychedelic Insights Announces Entheon Biomedical, Levitee Labs, and Women in Psychedelics to take centre stage at Psychedelic Capital: September 30, 2021 Sep 23, 2021 Read More
